Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

19.64
Delayed Data
As of 3:59pm ET
 +0.25 / +1.29%
Today’s Change
13.31
Today|||52-Week Range
24.57
+3.75%
Year-to-Date

Today’s Trading

Previous close19.39
Today’s open19.37
Day’s range19.17 - 19.75
Volume253,242
Average volume (3 months)405,879
Market cap$738.6M
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+5.94%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.15+0.53%
MYOVMyovant Sciences Ltd+0.16+1.24%
CRSPCRISPR Therapeutics ...-0.23-1.36%
JNCEJounce Therapeutics ...+0.09+0.36%
Data as of 4:00pm ET, 04/26/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs